Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH.
Levy WC, et al. Among authors: hellkamp as.
Circulation. 2009 Sep 8;120(10):835-42. doi: 10.1161/CIRCULATIONAHA.108.816884. Epub 2009 Aug 24.
Circulation. 2009.
PMID: 19704100
Free PMC article.
Clinical Trial.